欢迎点击【药用植物研究前沿】↑关注我们!内容来源于Journal of Natural Products
作为藏药藏锦鸡儿的基源植物鬼箭愁(鬼箭锦鸡儿,Caragana jubata),早在公元8世纪就被记载于藏药经典著作《四部医典》中。其根茎的红色心材被认为具有促进血液循环、抑制血瘀、降低血压的作用,常与其它中药合用于治疗缺血性心脑血管疾病。天津大学杨学东团队研究发现其中的查尔酮化合物具有显著的抗炎活性,并以题目“Anti-inflammatory Chalcone?Isoflavone Dimers and Chalcone Dimers from Caragana jubata”发表在Journal of Natural Products上。研究人员在鬼箭愁根状茎的红色心材中发现了两种新的查尔酮-异黄酮二聚体——锦鸡儿素A(1)和B(2),两种新的查尔酮二聚体——锦鸡儿素C(3)和D(4),以及八种已知化合物(5-12)。通过1D&2D核磁共振波谱、HRMS和ECD分析,并结合已知化合物的信息,最终确定了锦鸡儿素A-D的结构。他们提出了化合物(1-4)可能的生物合成途径。锦鸡儿素A和B的生物合成途径可能以亲核加成反应为主,即5,2′,4′-三羟基-7-甲氧基异黄酮攻击β-碳或2,4 -二甲氧基-4′-羟基查尔酮的羰基碳,进而烯醇化和还原反应分别产生1和2。锦鸡儿素 C和D的骨架来自于查尔酮,4,2′-二羟基-4′-甲氧基查尔酮通过还原和脱水转化为o-邻醌甲酰胺;然后o-邻醌甲酰胺与另一个查尔酮分子[4+2]环化加成。如果在环加成反应中使用的是o-邻醌甲酰胺和2,4-二甲氧基-4′-羟基查尔酮,环加成加合物还原反应产生3。通过亲核取代反应,环加成加合物o-邻醌甲酰胺和2,4′-二羟基-4-甲氧基查尔酮会形成桥环,然后还原反应产生4。通过测定脂多糖诱导的小鼠腹腔巨噬细胞系(264.7)中产生的NO、IL-6和 TNF-α,评价新化合物的抗炎活性。其中化合物2和4分别对一氧化氮的形成具有最强的抑制活性(IC50分别为4.1和5.2μM),化合物1和4对炎症因子TNF-α的分泌具有最强的抑制作用,IC50值分别为11.4和14.7μM。
Journal of Natural Products. online2 October 2019doi: 10.1021/acs.jnatprod.9b00365
Anti-inflammatory Chalcone–Isoflavone Dimers and Chalcone Dimers from Caragana jubataTwo new chalcone–isoflavone dimers, caraganins A (1) and B (2), two new chalcone dimers, caraganins C (3) and D (4), and eight known compounds (5–12) were obtained from the red heartwood of the rhizomes of Caragana jubata. The structures of caraganins A–D were established by 1D and 2D NMR spectroscopy, HRMS and ECD analysis, and comparison with previously known compounds. The anti-inflammatory activities of the new compounds were evaluated by measuring the production of NO, IL-6, and TNF-α in mouse RAW 264.7 macrophages induced by lipopolysaccharide. Among these, compounds 2 and 4 showed the most potent inhibitory activities (IC50: 4.1 and 5.2 μM, respectively) on nitric oxide formation, and compounds 1 and 4 displayed the most potent inhibitory activities on the secretion of inflammatory factor TNF-α, with IC50 values of 11.4 and 14.7 μM. The possible biosynthetic pathways of the chalcone–isoflavone dimers and the chalcone dimers are proposed.
如有投稿、建议、交流或发现违法、侵权、不良信息等,请发送邮件至yyzwyjqy@163.com与我们联系。
原文链接请点击下方阅读原文